Trobisch, Per
Mahoney, Jonathan M.
Eichenlaub, Emily K.
Antonacci, Christopher L.
Cuddihy, Laury
Amin, Dhara B.
Razo-Castaneda, Dominic
Orbach, Mattan R.
McGuckin, Joshua P. http://orcid.org/0000-0001-6426-4054
Bucklen, Brandon S.
Antonacci, M. Darryl
Betz, Randal R.
Article History
Received: 20 July 2022
Revised: 10 February 2023
Accepted: 13 February 2023
First Online: 5 March 2023
Declaration
:
: PDT receives consulting fees from GMI and Stryker Spine, and lecture fees from ZimVie and Triaspine. RRB receives royalties from GMI, DePuy Synthes Spine, SpineGuard, Thieme Medical Publishers; Speakers bureau payments from GMI and DePuy Synthes Spine; Consulting fees from GMI, DePuy Synthes Spine, SpineGuard, SpineWelding, Addivation, and Orthopediatric Corp and stock options from SpineGuard, SpineWelding, Orthopediatric Corp, Abyrx, Electrocore, H-CYTE, Life Unit, Molecular Surface Technologies, and Orthobond. RRB is also on the Life Unit and Molecular Surface Technologies boards and is the co-owner of NOFUSCO. CLA, LC, DRC, MRO, and MDA have no disclosures to report. EKE, JMM, DBA, JPM, and BSB are paid employees of GMI. JMM, JPM, and BSM also receive stock options from GMI.